Dr. Tonmoy Sharma, Sovereign Health’s Chief Executive Officer, said: “We’re thrilled with the addition of Dr. Veena Kumari to our executive leadership as Chief Scientific Officer. Dr. Kumari is a powerhouse in the field of psychology and neuroscience. As Sovereign Health continues to expand throughout the nation, our organization will benefit greatly by her leadership in taking our innovation and research to the next level.”
Throughout the course of her impressive career, Dr. Kumari has received various national and international awards for her research, including the Young Investigator Award from the National Alliance of Research on Schizophrenia and Depression, Senior Scientist award from the Schizophrenia Congress, and the Hans Eysenck Annual Scholarship award. She was awarded prestigious research fellowships from, BEIT Memorial Foundation and the Wellcome Trust, the British Association of Psychopharmacology Clinical Psychopharmacology Prize, and most recently the prestigious Humboldt Research Award in 2014, awarded in recognition of a researcher’s body of achievements.
Dr. Kumari is an internationally renowned authority on cognitive neuroscience and has published extensively in peer-reviewed journals on measures such as electromyography, electroencephalography, neuropsychology, structural and functional neuroimaging and genetics. She has over 250 publications in reputed psychology, psychiatry and neuroscience journals, with a current H index of 60 and over 11,000 cumulative citations. She has also supervised numerous post-graduate and doctoral students, many of whom have published high impact papers and have procured academic or leadership positions at reputed institutions.
She has served as an editor or as an editorial board member for many journals, including Personality & Individual Differences, Current Psychopharmacology, Psychiatry Research: Neuroimaging, Schizophrenia Research & Treatment, World Journal of Psychiatry, Peer J, and the Australian and New Zealand Journal of Psychiatry.